United Therapeutics

YTD

ALL

Trade United Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About UTHR

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin.

CEO

Martine A. Rothblatt

CEOMartine A. Rothblatt

Employees

1,400

Employees1,400

Headquarters

Silver Spring, Maryland

HeadquartersSilver Spring, Maryland

Founded

1996

Founded1996

Employees

1,400

Employees1,400

UTHR Key Statistics

Market cap

25.19B

Market cap25.19B

Price-Earnings ratio

21.01

Price-Earnings ratio21.01

Dividend yield

—

Dividend yield—

Average volume

640.57K

Average volume640.57K

High today

$595.00

High today$595.00

Low today

$576.24

Low today$576.24

Open price

$584.04

Open price$584.04

Volume

637.86K

Volume637.86K

52 Week high

$609.35

52 Week high$609.35

52 Week low

$409.07

52 Week low$409.07

Stock Snapshot

With a market cap of 25.19B, United Therapeutics(UTHR) trades at $587.50. The stock has a price-to-earnings ratio of 21.01.

On 2026-10-25, United Therapeutics(UTHR) stock moved within a range of $576.24 to $595.00. With shares now at $587.50, the stock is trading +2.0% above its intraday low and -1.3% below the session's peak.

Trading activity shows a volume of 637.86K, compared to an average daily volume of 640.57K.

The stock's 52-week range extends from a low of $409.07 to a high of $609.35.

UTHR News

Investing.com 1d

Martine Rothblatt, United Therapeutics CEO, sells $5.5M in stock - Investing.com

...

TipRanks 3d

United Therapeutics Announces $2 Billion Share Buyback

United Therapeutics ( (UTHR) ) just unveiled an announcement. On October 21, 2026, United Therapeutics Corporation’s board approved a new share repurchase prog...

TipRanks 3d

United Therapeutics announces new share repurchase program for up to $2B

United Therapeutics (UTHR) announced that the company’s Board of Directors has authorized a new share repurchase program for up to $2 billion of the company’s c...

Analyst ratings

82%

of 17 ratings

Buy

82.4%

Hold

11.8%

Sell

5.9%

More UTHR News

TipRanks 6d

United Therapeutics announces FDA clearance to proceed with SUMMIT trial

United Therapeutics (UTHR) announced that the U.S. Food and Drug Administration has granted clearance under the company’s investigational new drug application t...

People also own

Based on the portfolios of people who own UTHR. This list is generated using Robinhood data, and it’s not a recommendation.

Sterling Infrastructure

Argan

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.